SCHEMBL32688199

SCHEMBL32688199

N#Cc1c(-c2cccc(N3CCN(c4ccccc4)CC3)c2)cc(=O)[nH]c1SCc1nnn[nH]1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 2/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.35
▸ GAA P10253 2/20 0.35
▸ ALDH1A1 P00352 3/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ HPGD P15428 1/20 0.34
▸ ATM Q13315 1/20 0.34
▸ ADORA3 P0DMS8 1/20 0.34
▸ ADORA2A P29274 1/20 0.34
▸ ADORA2B P29275 1/20 0.34
▸ ADORA1 P30542 1/20 0.34
▸ DRD2 P14416 1/20 0.34
▸ DRD3 P35462 1/20 0.34
▸ KISS1R Q969F8 1/20 0.34
▸ MAPT P10636 2/20 0.34
▸ LMNA P02545 3/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688472 0.94 GRK6 (0.36) HSD11B1NPSR1ALDH1A1KMT2AHPGD
SCHEMBL32688425 0.93 KISS1R (0.39) NPSR1ALDH1A1DRD2DRD3KISS1R
SCHEMBL32688310 0.93 GRK6 (0.37) HSD11B1NPSR1ALDH1A1KMT2AHPGD
SCHEMBL32688223 0.93 KISS1R (0.35) HSD11B1GAAALDH1A1KMT2AHPGD
SCHEMBL32688163 0.92 KISS1R (0.39) DRD2DRD3KISS1RHTR1AHTR7
SCHEMBL32687963 0.90 USP2 (0.37) GAAALDH1A1KMT2AHPGDKISS1R
SCHEMBL32688418 0.88 HSD17B10 (0.40) GAAALDH1A1KMT2AHPGDKISS1R
SCHEMBL32688427 0.88 KISS1R (0.35) GAAALDH1A1KMT2AHPGDKISS1R
SCHEMBL32687986 0.87 KMT2A (0.39) HSD11B1GAAALDH1A1KMT2AHPGD
SCHEMBL32688274 0.85 BRD4 (0.38) HSD11B1GAAALDH1A1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK HSD11B1 61/4885NPSR1 2673/4885GAA 1309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback